CRDF

Cardiff Oncology, Inc. Common Stock

$1.90 +3.26%

Recent alerts on CRDF

All signals →

SEC filing CRDF Sues NMS Over Patent Inventorship, Seeks Injunction; NMS Terminates $150M Agreement

SEC filing CRDF Files Lawsuit Against Nerviano Medical Sciences, Disputes Alleged Material Breach of Onvansertib License Agreement

News Cardiff Oncology GAAP EPS of -$0.18 misses by $0.05, revenue of $0.04M misses by $0.04M

Short interest Short interest 26.2% of float

SEC filing CRDF Appoints Mani Mohindru CEO, Josh Muntner CFO, Ajay Aggarwal COO; Onvansertib Focus

Short volume Short volume 73% of volume (6.7σ)

News How Rocket Lab's New Contract Will Propel it to New Heights in 2026

Scanner Unusual volume (5.1x average)

Get push alerts for CRDF

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS